Lotfi Chouchane Selected Research

Lotfi Chouchane Research Topics

Disease

43	Neoplasms (Cancer) 01/2022 - 09/2002
21	Breast Neoplasms (Breast Cancer) 06/2021 - 09/2002
16	Nasopharyngeal Carcinoma 01/2016 - 09/2002
8	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 07/2006
7	Neoplasm Metastasis (Metastasis) 06/2021 - 09/2007
5	Lymphatic Metastasis 04/2013 - 01/2006
4	Carcinogenesis 01/2022 - 02/2008
4	Ductal Carcinoma 12/2012 - 11/2005
3	Melanoma (Melanoma, Malignant) 11/2020 - 04/2012
3	Infections 01/2020 - 04/2009
3	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 09/2002
2	Testicular Neoplasms (Testicular Cancer) 05/2014 - 04/2012
2	Disease Progression 04/2013 - 05/2011
2	Liver Cirrhosis (Hepatic Cirrhosis) 06/2011 - 04/2009
2	Hepatitis C 06/2011 - 04/2009
2	Chronic Hepatitis C 06/2011 - 04/2009
2	Carcinoma (Carcinomatosis) 04/2010 - 07/2006
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	COVID-19 01/2021
1	Inflammation (Inflammations) 12/2020
1	Chronic Disease (Chronic Diseases) 12/2020
1	Familial Mediterranean Fever (Periodic Disease) 10/2020
1	Xeroderma Pigmentosum (Kaposi's Disease) 01/2020
1	Squamous Intraepithelial Lesions 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Triple Negative Breast Neoplasms 01/2017
1	Stomach Neoplasms (Stomach Cancer) 05/2015
1	Dyslipidemias (Dyslipidemia) 01/2014
1	Medullary Carcinoma 12/2012
1	Lobular Carcinoma 12/2012

Drug/Important Bio-Agent (IBA)

10	Genetic Markers (Genetic Marker)IBA 10/2012 - 05/2005
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2002
8	EnzymesIBA 01/2016 - 05/2005
4	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2015
4	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 09/2008
4	Molecular Chaperones (Chaperone, Molecular)IBA 12/2012 - 02/2008
4	HLA Antigens (Human Leukocyte Antigens)IBA 08/2011 - 04/2003
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2010 - 07/2006
3	AntibodiesIBA 01/2021 - 07/2008
3	Immunoglobulin G (IgG)IBA 01/2020 - 09/2002
3	Cadherins (E-Cadherin)IBA 01/2017 - 09/2010
3	AntigensIBA 05/2014 - 07/2008
3	Biomarkers (Surrogate Marker)IBA 10/2012 - 06/2009
3	CytokinesIBA 06/2011 - 12/2005
3	Interleukin-8 (Interleukin 8)IBA 06/2010 - 01/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2007 - 04/2003
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020 - 01/2017
2	Hormones (Hormone)IBA 01/2019 - 12/2012
2	Formaldehyde (Formol)FDA Link 12/2017 - 06/2009
2	ParaffinIBA 12/2017 - 06/2009
2	Biological ProductsIBA 12/2017 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 05/2015 - 12/2005
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2015 - 01/2009
2	InterferonsIBA 08/2011 - 06/2011
2	Interleukin-10 (Interleukin 10)IBA 06/2011 - 04/2009
2	Interleukin-18 (Interleukin 18)IBA 06/2011 - 08/2008
2	ChemokinesIBA 06/2010 - 09/2007
2	HaptoglobinsIBA 06/2009 - 07/2008
2	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 04/2009 - 09/2007
2	TubulinIBA 07/2008 - 09/2002
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2008 - 04/2003
2	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 02/2008 - 01/2008
2	Phosphopyruvate Hydratase (Enolase)IBA 02/2008 - 01/2008
2	AutoantibodiesIBA 02/2006 - 09/2002
1	Immune Checkpoint InhibitorsIBA 01/2022
1	human MIRN149 microRNAIBA 01/2022
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 01/2022
1	Protein Kinase InhibitorsIBA 01/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 12/2020
1	RNA (Ribonucleic Acid)IBA 11/2020
1	Amino Acids FDA Link 11/2020
1	Interleukin-33IBA 10/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2019
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2018
1	Small Untranslated RNAIBA 12/2017
1	NeuropeptidesIBA 01/2017
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2017
1	Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA 01/2017
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2016
1	Dinoprostone (PGE2)FDA Link 05/2015
1	InterleukinsIBA 05/2015
1	ApolipoproteinsIBA 01/2014
1	Triglycerides (Triacylglycerol)IBA 01/2014
1	Messenger RNA (mRNA)IBA 05/2013
1	CalreticulinIBA 04/2013
1	Crystallins (Crystallin)IBA 12/2012
1	P-2 (P 2)IBA 10/2012

Therapy/Procedure

9	Therapeutics 06/2021 - 09/2002
5	Immunotherapy 01/2022 - 04/2012
5	Lasers (Laser) 04/2013 - 01/2008
2	Precision Medicine 12/2020 - 01/2017
2	Aftercare (After-Treatment) 05/2011 - 04/2008
1	Castration 01/2019
1	Drug Prescriptions 01/2018